| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.0007 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.21 | 0.0008 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.001 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.001 |